
About Kronox Lab Sciences Limited
Data last updated:
Kronox Lab Sciences Limited is a public limited company based in Padra, Gujarat, India. It specialises in chemical products, a part of the broader chemicals sector. Incorporated on 18 November 2008, the company has been in operation for over 18 years.
Registered with ROC Ahmedabad under CIN L24117GJ2008PLC055460. Listed.
Capital: an authorised share capital of ₹54 Cr and a paid-up capital of ₹37.1 Cr. Formerly known as Kronox Lab Sciences Private Limited. It is led by directors including Jogindersingh Gianchand Jaswal and Ketan Ramani.
Last AGM: 18 August 2025. Financial statements filed for year ended 31 March 2025. Office: Block No. 353 Village Ekalbara, Padra, Gujarat, India – 391440.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹101.22 Cr, a growth of 1.03% compared to the previous year. The net worth stands at ₹116.12 Cr (up 28.88% YoY). Total assets are valued at ₹117.76 Cr (up 30.66% YoY).
The company has a workforce of approximately 70 employees as per the latest available data.
The company is associated with 1 brand - Kronox Lab Sciences. As per MCA filings, the company has open charges of ₹2.03 Cr and satisfied charges of ₹5.99 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kronoxlabsciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressBlock No. 353 Village Ekalbara, Padra, Gujarat, India – 391440
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Kronox Lab Sciences
Kronox Lab Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24117GJ2008PLC055460, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24117GJ2008PLC055460 | Current |
| U24117GJ2008PLC055460 | Previous |
| U24117GJ2008PTC055460 | Previous |
Associated Brands with Kronox Lab Sciences
Kronox Lab Sciences operates one associated brand: KRONOX Lab Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of high purity fine chemicals, specializing in chemical synthesis and analysis | kronoxlabsciences.com |
Business Activity of Kronox Lab Sciences
The main business activity of Kronox Lab Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Kronox Lab Sciences Limited
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Kronox Lab Sciences
Kronox Lab Sciences Limited is audited by Mahesh Udhwani & Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Mahesh Udhwani & Associates | Locked | Locked | Locked |
Complete auditor history for Kronox Lab Sciences Limited
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kronox Lab Sciences Limited
Kronox Lab Sciences has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jogindersingh Gianchand Jaswal | Managing Director | 18 Nov 2008 | 17 Years 10 Months | Current |
| Ketan Ramani Also directs: P.K.Chlorochem Private Limited | Whole-Time Director | 18 Nov 2008 | 17 Years 10 Months | Current |
| Pritesh Vinodchandra Ramani | Whole-Time Director | 18 Nov 2008 | 17 Years 10 Months | Current |
| Krutika Arunkumar Negandhi | Director | 23 Aug 2022 | 4 Years 1 Months | Current |
| Parth B Shah | Director | 23 Aug 2022 | 4 Years 1 Months | Current |
| Satish Kumar | Director | 23 Aug 2022 | 4 Years 1 Months | Current |
Financials of Kronox Lab Sciences Limited FY 2025-26 filings available
Kronox Lab Sciences Limited reported revenue of ₹101.22 Cr (up 1.03% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 101 | 100 | 89.86 | 95.58 | 82.25 | 62.46 | 50.50 |
| Revenue growth | -0.2% | +9.0% | -16.7% | +18.1% | +31.3% | +22.9% | +9997.0% |
| EBITDA | 34.27 | 33.12 | 28.33 | 21.71 | 19.69 | 14.80 | 11.71 |
| EBITDA margin | +33.9% | +33.1% | +31.5% | +22.7% | +23.9% | +23.7% | +23.2% |
| Profit before tax | 37.30 | 34.27 | 28.62 | 22.04 | 18.34 | 13.22 | 11.74 |
| Net profit | 27.60 | 25.47 | 21.36 | 16.39 | 13.59 | 9.71 | 8.60 |
| Net profit margin | +27.3% | +25.4% | +23.8% | +17.2% | +16.5% | +15.6% | +17.0% |
| EPS (₹) | 7.45 | 6.86 | 5.75 | 4.42 | 565.44 | 403.73 | 343.75 |
| Balance sheet | |||||||
| Total assets | 118 | 90.13 | 66.32 | 45.24 | 44.23 | 30.61 | 23.40 |
| Net worth | 116 | 90.10 | 66.30 | 44.75 | 40.35 | 26.81 | 23.34 |
| Total debt | 1.61 | 0.00 | 0.00 | 0.00 | 3.36 | 3.62 | 0.03 |
| Cash & bank | 48.74 | 36.68 | 3.64 | 3.56 | 2.81 | 2.05 | 2.48 |
| Net working capital | 69.09 | 54.60 | 38.93 | 25.38 | 31.60 | 19.17 | 16.27 |
| Cash flow | |||||||
| Cash from operations | 23.89 | 30.70 | 17.42 | 19.67 | 9.02 | 11.31 | 4.48 |
| Cash from investing | (23.82) | (28.39) | (17.31) | (6.60) | (7.60) | (2.96) | (3.92) |
| Cash from financing | (0.36) | (1.85) | 0.00 | (13.40) | (0.67) | (7.10) | (0.21) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 28.39 | 26.13 | 25.27 | 25.53 | 24.29 | 26.13 | 24.01 | 24.86 |
| Revenue growth (YoY) | +16.9% | 0.0% | +5.3% | +2.7% | -3.6% | +17.8% | +15.9% | +18.3% |
| Other income | 1.30 | 2.15 | 1.13 | 1.04 | 0.87 | 0.91 | 0.82 | 0.36 |
| Total expenses | 19.39 | 16.61 | 17.25 | 16.89 | 16.32 | 18.38 | 15.65 | 16.06 |
| EBITDA | 9.00 | 9.52 | 8.02 | 8.64 | 7.97 | 7.75 | 8.36 | 8.80 |
| EBITDA margin | +31.7% | +36.4% | +31.7% | +33.8% | +32.8% | +29.7% | +34.8% | +35.4% |
| Depreciation | 0.45 | 0.66 | 0.52 | 0.47 | 0.40 | 0.35 | 0.36 | 0.34 |
| Interest | 0.03 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 9.82 | 10.97 | 8.59 | 9.17 | 8.44 | 8.31 | 8.82 | 8.82 |
| Tax | 2.51 | 2.96 | 2.01 | 2.50 | 2.17 | 2.00 | 2.30 | 2.35 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 28.39 | 26.13 | 25.27 | 25.53 | 24.29 | 26.13 | 24.01 | 24.86 |
| Revenue growth (YoY) | +16.9% | 0.0% | +5.3% | +2.7% | -3.6% | +17.8% | +15.9% | +18.3% |
| Other income | 1.30 | 2.15 | 1.13 | 1.04 | 0.87 | 0.91 | 0.82 | 0.36 |
| Total expenses | 19.39 | 16.61 | 17.25 | 16.89 | 16.32 | 18.38 | 15.65 | 16.06 |
| EBITDA | 9.00 | 9.52 | 8.02 | 8.64 | 7.97 | 7.75 | 8.36 | 8.80 |
| EBITDA margin | +31.7% | +36.4% | +31.7% | +33.8% | +32.8% | +29.7% | +34.8% | +35.4% |
| Depreciation | 0.45 | 0.66 | 0.52 | 0.47 | 0.40 | 0.35 | 0.36 | 0.34 |
| Interest | 0.03 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 9.82 | 10.97 | 8.59 | 9.17 | 8.44 | 8.31 | 8.82 | 8.82 |
| Tax | 2.51 | 2.96 | 2.01 | 2.50 | 2.17 | 2.00 | 2.30 | 2.35 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 101 | 100 | 89.86 | 95.58 | 82.25 | 62.46 | 50.50 |
| Revenue growth | -0.2% | +9.0% | -16.7% | +18.1% | +31.3% | +22.9% | +9997.0% |
| Other income | 5.19 | 2.53 | 1.58 | 1.92 | 1.09 | 0.78 | 1.07 |
| Total expenses | 66.95 | 67.07 | 61.53 | 73.87 | 62.56 | 47.66 | 38.79 |
| Employee cost | 3.44 | 2.95 | 2.50 | 1.93 | 1.65 | 1.49 | 1.20 |
| EBITDA | 34.27 | 33.12 | 28.33 | 21.71 | 19.69 | 14.80 | 11.71 |
| EBITDA margin | +33.9% | +33.1% | +31.5% | +22.7% | +23.9% | +23.7% | +23.2% |
| Depreciation | 2.05 | 1.38 | 1.29 | 1.50 | 2.03 | 1.98 | 0.96 |
| Interest | 0.11 | 0.00 | 0.00 | 0.09 | 0.41 | 0.38 | 0.08 |
| Profit before tax | 37.30 | 34.27 | 28.62 | 22.04 | 18.34 | 13.22 | 11.74 |
| Tax | 9.64 | 8.80 | 7.26 | 5.64 | 4.73 | 3.49 | 3.14 |
| Net profit | 27.60 | 25.47 | 21.36 | 16.39 | 13.59 | 9.71 | 8.60 |
| Net profit margin | +27.3% | +25.4% | +23.8% | +17.2% | +16.5% | +15.6% | +17.0% |
| EPS (₹) | 7.45 | 6.86 | 5.75 | 4.42 | 565.44 | 403.73 | 343.75 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 37.10 | 37.10 | 37.10 | 37.10 | 0.24 | 0.24 | 0.25 |
| Reserves & surplus | 79.02 | 53.00 | 29.20 | 7.65 | 40.11 | 26.57 | 23.09 |
| Shareholders' funds (net worth) | 116 | 90.10 | 66.30 | 44.75 | 40.35 | 26.81 | 23.34 |
| Secured loans | 1.61 | 0.00 | 0.00 | 0.00 | 0.17 | 0.01 | 0.03 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 3.19 | 3.61 | 0.00 |
| Total debt | 1.61 | 0.00 | 0.00 | 0.00 | 3.36 | 3.62 | 0.03 |
| Total liabilities | 118 | 90.13 | 66.32 | 45.24 | 44.23 | 30.61 | 23.40 |
| Assets | |||||||
| Gross block | 42.88 | 40.31 | 37.48 | 25.69 | 21.74 | 17.71 | 12.19 |
| Net block | 28.73 | 27.86 | 26.41 | 15.91 | 11.30 | 9.19 | 5.54 |
| Capital work in progress | 0.88 | 0.76 | 0.49 | 0.00 | 0.00 | 0.40 | 0.00 |
| Investments | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Inventories | 8.37 | 6.37 | 9.25 | 9.17 | 7.51 | 5.49 | 5.04 |
| Sundry debtors | 21.19 | 19.89 | 17.65 | 18.55 | 25.80 | 15.44 | 15.19 |
| Cash & bank balances | 48.74 | 36.68 | 3.64 | 3.56 | 2.81 | 2.05 | 2.48 |
| Loans & advances | 0.55 | 0.36 | 16.06 | 2.90 | 8.04 | 3.23 | 4.39 |
| Total current assets | 78.85 | 63.30 | 46.60 | 34.18 | 44.16 | 26.21 | 27.10 |
| Total current liabilities | 9.76 | 8.70 | 7.67 | 8.80 | 12.56 | 7.04 | 10.83 |
| Net working capital | 69.09 | 54.60 | 38.93 | 25.38 | 31.60 | 19.17 | 16.27 |
| Total assets | 118 | 90.13 | 66.32 | 45.24 | 44.23 | 30.61 | 23.40 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 3.04 | 2.59 | 2.48 | 2.81 | 2.05 | 0.79 | 0.44 |
| Net cash from operating activities | 23.89 | 30.70 | 17.42 | 19.67 | 9.02 | 11.31 | 4.48 |
| Net cash from investing activities | (23.82) | (28.39) | (17.31) | (6.60) | (7.60) | (2.96) | (3.92) |
| Net cash from financing activities | (0.36) | (1.85) | 0.00 | (13.40) | (0.67) | (7.10) | (0.21) |
| Net change in cash | (0.29) | 0.45 | 0.10 | (0.33) | 0.76 | 1.26 | 0.35 |
| Closing cash | 48.74 | 36.68 | 3.64 | 3.56 | 2.81 | 2.05 | 2.48 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +1.0% | +11.5% | -6.0% | +16.2% | +31.7% | +23.7% | +9997.0% |
| EBITDA growth | +3.5% | +16.9% | +30.5% | +10.3% | +33.0% | +26.4% | +9997.0% |
| PBT growth | +8.8% | +19.7% | +29.9% | +20.2% | +38.7% | +12.6% | +9997.0% |
| Net income growth | +8.4% | +19.2% | +30.3% | +20.6% | +40.0% | +12.9% | +9997.0% |
| Revenue CAGR (3Y) | +1.9% | +6.8% | +12.9% | +23.7% | - | - | - |
| EBITDA CAGR (3Y) | +16.4% | +18.9% | +24.2% | +22.9% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +27.3% | +25.4% | +23.8% | +17.2% | +16.6% | +15.6% | +17.0% |
| Return on capital employed | +36.0% | +43.8% | +51.3% | +50.2% | +50.2% | +50.4% | +50.5% |
| Return on net worth | +26.8% | +32.6% | +38.5% | +39.1% | +40.6% | +38.8% | +36.8% |
| Debt / equity | 0.01 | 0.00 | 0.00 | 0.04 | 0.10 | 0.07 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.03 | 0.07 | 0.05 | 0.00 |
| Interest cover | 0.34 | 0.00 | 0.00 | 0.45 | 2.32 | 2.96 | 0.74 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.43 | 2.58 | 2.85 | 4.03 | 4.17 | 4.18 | 4.14 |
| Inventory turnover | 13.73 | 12.83 | 9.76 | 11.46 | 12.65 | 11.86 | 10.02 |
| Debtors turnover | 4.93 | 5.34 | 4.96 | 4.31 | 3.99 | 4.08 | 3.32 |
| EPS (₹) | 7.45 | 6.86 | 5.75 | 4.42 | 565.44 | 403.73 | 343.75 |
| Dividend per share (₹) | 0.50 | 0.50 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 31.30 | 24.28 | 17.87 | 12.06 | 1,674.40 | 1,112.61 | 933.52 |
Shareholding Pattern of Kronox Lab Sciences Limited
Shareholding for the quarter ended Sep 2026: promoters hold 74.20%, foreign institutional investors hold 0.00%, domestic institutional investors hold 2.10% and retail and other public shareholders hold 23.70%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 74.20% | 74.20% | 74.20% | 74.20% |
| Public | 25.80% | 25.80% | 25.80% | 25.80% |
Charges & Borrowings of Kronox Lab Sciences
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jun 2025 | Hdfc Bank Limited | ₹2.03 Cr | Open |
| 29 Jul 2021 | Hdfc Bank Limited | ₹21.69 Lakh | Satisfied |
| 06 Apr 2021 | Hdfc Bank Limited | ₹56.07 Lakh | Satisfied |
| 23 Dec 2010 | Bank of India | ₹45 Lakh | Satisfied |
| 27 Jul 2009 | Bank of India | ₹4.77 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Kronox Lab Sciences
Kronox Lab Sciences Limited has a workforce of 70 employees as of Apr 09, 2025.
Employee and EPFO history for Kronox Lab Sciences Limited
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Kronox Lab Sciences
GST registrations and filing compliance for Kronox Lab Sciences Limited
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Kronox Lab Sciences
Credit ratings, litigation, and regulatory alerts for Kronox Lab Sciences Limited
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kronox Lab Sciences
MSME payment history for Kronox Lab Sciences Limited
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kronox Lab Sciences
Corporate group structure for Kronox Lab Sciences Limited
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kronox Lab Sciences
MCA filings and documents for Kronox Lab Sciences Limited
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Kronox Lab Sciences
Frequently Asked Questions about Kronox Lab Sciences Limited
Kronox Lab Sciences is an active public limited company in the chemicals sector based in Padra, Gujarat, India. It was incorporated on 18 November 2008 (18+ years old) and is registered under CIN L24117GJ2008PLC055460. The company has 70 employees.
Kronox Lab Sciences reported revenue of ₹101.22 Cr for FY 2025-26 (up 1.03% YoY) based on standalone financials.
The current directors of Kronox Lab Sciences are:
- Jogindersingh Gianchand Jaswal - Managing Director
- Ketan Ramani - Whole-Time Director
- Pritesh Vinodchandra Ramani - Whole-Time Director
- Krutika Arunkumar Negandhi - Director
- Parth B Shah - Director
- Satish Kumar - Director
The primary industry of Kronox Lab Sciences is chemicals. The company specifically operates in chemical products. The company is currently active in this sector.
Yes, Kronox Lab Sciences is a listed company.
Kronox Lab Sciences can be reached at the registered office: Block No. 353 Village Ekalbara, Padra, Gujarat, India – 391440, or through the website kronoxlabsciences.com.